InfuSystem Holdings, Inc (INFU)
| Market Cap | 263.60M+34.8% |
| Revenue (ttm) | 143.34M |
| Net Income | 8.54M |
| EPS | 0.40 |
| Shares Out | 19.92M |
| PE Ratio | 33.09 |
| Forward PE | 25.45 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 8,341 |
| Open | 13.25 |
| Previous Close | 13.33 |
| Day's Range | 13.09 - 13.34 |
| 52-Week Range | 7.29 - 13.85 |
| Beta | 1.49 |
| Analysts | Strong Buy |
| Price Target | 16.83(+27.19%) |
| Earnings Date | Nov 3, 2026 |
Insiders here have filed 1 Form 4 in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
About INFU
InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps and related products and services in the United States and Canada. It operates through two segments: Patient Services and Device Solutions. The company supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. It also sells and rents new and pre-owned pole-mounted and ambulatory infusion pumps, and other durable medical equipment; sells treatment-related consumables; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other healthcare site settings comprising hospitals, home care and home infusion providers, skilled nursing and acute care facilities, pain centers, and others. In addition, the company offers local and field-based customer support, as well as operates pump service and repair centers. The company was incorporated in 2005 and is headquartered in Rochester Hills, Michigan.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
$INFU stock is featured in our Insider Trades datasets.
→ All Stock ListsRecently reported changes in INFU holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by INFU's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
INFU Estimated quarterly lobbying spending
Source: U.S. Senate LDA
INFU Revenue by Segment
| Segment | Revenue | % of All |
|---|---|---|
| Patient Services and Device Solutions | $29.00M | 66.92% |
| Lease revenue | $7.93M | 18.31% |
| Product Sales | $3.74M | 8.64% |
| Services | $2.65M | 6.12% |
As of: Q2 2026 (Jun 30, 2026) · Source: SEC EDGAR (10-Q)
U.S. Patents
New INFU patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to INFU from public contracts
Source: USAspending.gov
INFU Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from INFU’s recent data — informational, not investment advice